Scientific Advisors

Kidney cancer research is a fast-moving space. The following Advisory Board members provide guidance and ensure we stay up-to-date.

“Kidney cancer is the ideal sandbox for new approaches, and without a doubt these approaches can, should, and will be suitable for other cancers.”

Dr. Hans Hammers

Mehmet Bilen, MD

Assistant Professor, Department of Hematology and Medical Oncology, Emory University School of Medicine.
Director, Genitourinary Medical Oncology Program, Winship Cancer Institute of Emory University.
Associate Medical Director, Phase I Unit,
Winship Cancer Institute of Emory University

Gennady Bratslavsky, MD

Professor and Chair of Urology Professor of Biochemistry and Molecular Biology Division Chief of Upstate Urology at 550 Harrison Division Chief of Urologic Male Health Director of Prostate Cancer Program Department Chief of Adult Urology Clinic Department Chief of Urologic Oncology

James Brugarolas, MD, PhD

Professor of Internal Medicine, Cancer Biology, Genetics, Development and Disease. The founding Director of the Kidney Cancer Program at UT Southwestern Simmons Cancer Center and Principal Investigator of one of two Specialized Programs of Research Excellence (SPORE) in kidney cancer in the U.S.

Toni Choueiri, MD

Director of the Lank Center for Genitourinary (GU) Oncology at Dana-Farber Cancer Institute/Brigham and Women’s Hospital and the Jerome and Nancy Kohlberg Chair and Professor of Medicine at Harvard Medical School.

Rachel Giles, MD

Staff, Internal Medicine Dept. Nephrology and Hypertension
University Medical Center Utrecht, The Netherlands
Chair – IKCC Board

Hans Hammers, MD, PHD

Associate Professor of Internal Medicine in the Division of Hematology-Oncology at UT Southwestern Medical Center. Co-leader of clinical research of the Kidney Cancer Program at Simmons Cancer Center.

Eric Jonasch, MD

Professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Payal Kapur, MD

Dr. Kapur is on faculty in the Department of Pathology and Urology at UT Southwestern and the Group Leader of Genitourinary Pathology and the Co-Leader of the Kidney Cancer Program at Simmons Cancer Center.

Marc Michaelson, MD, PhD

Director, Massachusetts General Hospital Hematology/Oncology Fellowship Program

Mehdi Mollapour, PhD

Professor, Vice Chair for Translational Research and Director of Renal Cancer Biology Program for the Department of Urology. Adjunct Professor at the Department of Biochemistry and Molecular Biology at SUNY Upstate Medical University.

Eric Singer, MD, MA, FACS

Associate Chief of Urology
Director, Kidney Cancer Program
Rutgers Cancer Institute of New Jersey
Associate Professor of Surgery and Radiology

Ramaprasad Srinivasan, MD, PHD

Investigator Urologic Oncology Branch Head, Molecular Cancer Therapeutics Section NCI
KCRS22 October 6-7, 2022

 KCRS is an annual meeting focused on basic, translational, and clinical kidney cancer research. The meeting is fueled by the ideas and research funded through the Department of Defense CDMRP-KCRP awards.

The goal for KCRS is to present the important, innovative research funded by the KCRP. We also aim to connect researchers from around the world to share their work.

KCRS22 WILL BE HELD ON OCTOBER 6-7, 2022

For Patients

Advocacy

Research

WHO WE ARE →

WHAT WE DO →

OUR STORIES →

THE KIDNEY CANCER COMMUNITY →

SCIENTIFIC ADVISORS →

DONATE →

CONTACT →

Latest News

Remembering Ralph: Time Well Spent

Remembering Ralph: Time Well Spent

Ralph Knapp was diagnosed in 2014 with stage IV kidney cancer and used the opportunity to increase research funding and bring hope to patients everywhere. With heavy hearts and profound sadness, we announce the passing of Ralph Knapp, a founder of KidneyCAN and leader of our mission to accelerate...

SPRING ADVOCACY DAYS 2022 →

JOIN OUR COMMUNITY →

RAISING AWARENESS →

BE AN ADVOCATE →

DONATE NOW →

CONTACT →

Latest News

Let’s Get Loud: Spring 2022 Advocacy Days

Let’s Get Loud: Spring 2022 Advocacy Days

On March 7-8, KidneyCAN gathered advocates from all over the United States to ask Congress for robust funding for kidney cancer research through the NIH and CDMRP (Congressionally Directed Medical Research Programs). Read on to hear about our goals for this event and how you can help fund...

Patient Resource Center

UNDERSTANDING YOUR KIDNEY CANCER DIAGNOSIS

BUILDING A CARE TEAM

TREATMENT & TRIAL OPTIONS

LIVING WELL WITH KIDNEY CANCER

KCRS: KIDNEY CANCER RESEARCH SUMMIT →

RESEARCH OPPORTUNITIES →

NEWS →

Latest News

IKCC Report: Retention in Clinical Trials

IKCC Report: Retention in Clinical Trials

The International Kidney Cancer Coalition launched a pilot program to understand the barriers and other considerations that drive the decision to leave a clinical trial and uncover ways to better support patients currently in or considering joining clinical trials. Clinical trials are the key to...

SUPPORT OUR WORK →

FUNDRAISE FOR KIDNEYCAN →

DONATE →

CONTACT →

Latest News

Remembering Ralph: Time Well Spent

Remembering Ralph: Time Well Spent

Ralph Knapp was diagnosed in 2014 with stage IV kidney cancer and used the opportunity to increase research funding and bring hope to patients everywhere. With heavy hearts and profound sadness, we announce the passing of Ralph Knapp, a founder of KidneyCAN and leader of our mission to accelerate...